TOP TIERMARKET NEWSWIRE
News & sentiment

BRIDGEBIO PHARMA INC (BBIO) — News & AI sentiment

BRIDGEBIO PHARMA INC (BBIO) news roundup. 2 stories in the past week, 29 over 30 days. Average 30-day sentiment is 58.4/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $4.6M — net selling of $4.6M. US House Periodic Transaction Reports (90-day window): 0 purchases (~$0) and 2 sales (~$16K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 50/100
30d stories
29
avg sentiment 58.4/100
Insider net (90d)
$4.6M
0 buys · 3 sells
Congress (90d)
-2
0 buys · 2 sells

BBIO news in the last 24 hours, 7 days, 30 days and 90 days

How much BBIO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowBBIO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days250/100BBIO headlines →
Last 30 days2958.4/100BBIO headlines →
Last 90 days9554.3/100BBIO headlines →

Latest stories on BBIO

6d ago
6d ago
Oct 21
Oct 19
Oct 19
Oct 16
Oct 16
H.C. Wainwright reiterates Buy on BridgeBio stock, cites trial data
Investing.com Analyst Ratings63 · neutralanalyst
Oct 15
Oct 15
Oct 13
BridgeBio Pharma, Inc. (BBIO) files 8-K
SEC 8-K50 · neutralgeneral
Oct 13
Truist previews biotech earnings with focus on Insmed, BridgeBio
Investing.com Analyst Ratings55 · neutralanalyst
Oct 12
Oct 11
Oct 11
Oct 11
Oct 7
Oct 6
Oct 6
Oct 6
William Blair reiterates Outperform on BridgeBio Pharma stock
Investing.com Analyst Ratings61 · neutralanalyst
Oct 6
Oct 6
Oct 6
Oct 6
Oct 6
Oct 5
Open BBIO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →